Home Cart Sign in  
Chemical Structure| 120926-46-7 Chemical Structure| 120926-46-7

Structure of Isoliquiritin apioside
CAS No.: 120926-46-7

Chemical Structure| 120926-46-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Isoliquiritin apioside is a natural product isolated and purified from the roots of Glycyrrhiza uralensis with marked potential to combat oxidative stress-induced genotoxicity.

Synonyms: ISLA; ILA

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Isoliquiritin apioside

CAS No. :120926-46-7
Formula : C26H30O13
M.W : 550.51
SMILES Code : O=C(C1=CC=C(O)C=C1O)/C=C/C2=CC=C(O[C@H]3[C@H](O[C@@H]4OC[C@@](CO)(O)[C@H]4O)[C@@H](O)[C@H](O)[C@@H](CO)O3)C=C2
Synonyms :
ISLA; ILA
MDL No. :MFCD20487832
InChI Key :VMMVZVPAYFZNBM-KVFWHIKKSA-N
Pubchem ID :6442433

Safety of Isoliquiritin apioside

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Related Pathways of Isoliquiritin apioside

MAPK
pyroptosis
TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HUVECs 100 μM 15 hours To evaluate the effect of ISLA on HUVECs migration and tube formation ability, results showed that ISLA significantly inhibited HUVECs migration and tube formation Front Pharmacol. 2018 Dec 10;9:1455
HT1080 cells 100 μM 24 hours To evaluate the effect of ISLA on HT1080 cell migration and invasion ability, results showed that ISLA significantly inhibited cell migration and invasion Front Pharmacol. 2018 Dec 10;9:1455
HT1080 cells 100 μM 48 hours To evaluate the effect of ISLA on HT1080 cell proliferation, results showed that 100 μM ISLA did not reduce cell viability but slightly increased it by approximately 10% Front Pharmacol. 2018 Dec 10;9:1455
HUVECs 100 μM 15 hours To evaluate the effect of ISLA on HUVECs migration and tube formation ability, results showed that ISLA significantly inhibited EGM-2-induced migration and tube formation. Front Pharmacol. 2018 Dec 10;9:1455
HT1080 cells 100 μM 24 hours To evaluate the effect of ISLA on HT1080 cell migration and invasion ability, results showed that ISLA significantly inhibited serum-induced migration and invasion. Front Pharmacol. 2018 Dec 10;9:1455
HT1080 cells 100 μM 48 hours To evaluate the effect of ISLA on HT1080 cell proliferation, results showed that 100 μM ISLA did not decrease cell viability but slightly increased it by approximately 10%. Front Pharmacol. 2018 Dec 10;9:1455

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats Oral 6.67 mg/kg Single dose To study the pharmacokinetic behavior of Isoliquiritin apioside in rats. Results showed that the AUC0-24 h in the broad-spectrum antibiotic-pretreated group was decreased by 44.1% compared with the control group. Acta Pharmacol Sin. 2019 Feb;40(2):288-296
Chick embryos Chorioallantoic membrane (CAM) model Topical administration 100 μg Single administration, lasting 3 days To evaluate the effect of ISLA on vessel formation, results showed that ISLA significantly inhibited VEGF-induced vessel formation Front Pharmacol. 2018 Dec 10;9:1455

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.82mL

0.36mL

0.18mL

9.08mL

1.82mL

0.91mL

18.16mL

3.63mL

1.82mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories